SETBP1 mutation analysis in 944 patients with MDS and AML.
about
Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literatureA novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case.Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.Clinical and genetic predictors of prognosis in myelodysplastic syndromes.Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease.Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemiaThe molecular basis of myeloid malignancies.SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies.Somatic SETBP1 mutations in myeloid malignanciesDonor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation.Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome.Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia.I walk the line: how to tell MDS from other bone marrow failure conditions.The molecular pathogenesis of the myelodysplastic syndromes.Next-generation sequencing-based panel testing for myeloid neoplasms.Therapy-related myeloid neoplasms: when genetics and environment collide.Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.Genomics of chronic neutrophilic leukemia.Somatic SETBP1 mutations in myeloid neoplasms.A novel mutation of SETBP1 in atypical chronic myeloid leukemia transformed from acute myelomonocytic leukemia.Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group.Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemiaSETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.Genetic characterization of acquired aplastic anemia by targeted sequencing.Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q.Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia.SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.
P2860
Q28083489-F4DD252B-B341-4963-B545-DC67433EDA55Q30152631-3B9F39FA-54AB-4D44-B107-8DB0B59FB5E0Q33591367-42EC7B1F-C001-4A06-A4ED-1EF64FC9690CQ33695906-8E8EC2EC-8F32-4942-855B-242FD1B8FD26Q34667249-57B98A33-C944-40C5-9D54-37958E918AF3Q34749589-F2387570-779B-4776-9CF4-BCA89E338381Q35103708-316DE399-7F5C-4B91-8223-94B112C73733Q35849733-F9493042-6ADF-4D8E-BAF9-B2F221955A15Q36270003-9BBF6D29-EAB2-40BB-8898-1906D5BF7B85Q36323864-C05D1EB9-BC2E-494E-87CA-B0CD29A90DE1Q37060418-F57F87FE-8E8A-4286-B582-96FC6119E0C0Q37239107-FB775AAF-7E46-4D93-A441-2B0D0AFBB832Q37688233-27F3A618-3250-4A07-8306-2853358639F9Q37707099-69408A36-7BCE-41AA-A71F-B9FCD509E256Q38235622-D73F9C17-E3CF-4499-BE29-E8294786F747Q38341998-E07880BD-15B5-4ED3-8F21-1546302179E0Q38453790-29EE2BE9-DCB6-4B85-805A-E27B287277D4Q38611096-26681CAE-48A1-4948-AD00-CEE41B6008CBQ38678287-1139F678-4C02-403F-8D3E-7DC3C4816E87Q38726652-69D8A917-3C54-44C3-A67A-7D51E0EE266EQ39059515-403D2F95-6E68-42AC-8EA3-EE91AE82B0EFQ39266051-C2E66C5C-3FC3-46BD-B06E-3CA6F3CBA27CQ40725420-D4472FDB-76E3-407C-9553-01476D94B419Q41259945-433688AB-597A-486D-B246-571F85B264A2Q42660724-83B669E0-A76C-42FC-927F-B4B534C579BDQ43135315-B8104123-A5C8-4C30-80F4-90FF8DA7D9FFQ43135419-802DBE06-3A5F-49B6-90FE-2A3218503DB1Q43428613-27B1E1A8-4847-4077-A411-17CB4EA5B9E8Q47797877-D67CF76F-F02B-4E3F-9F15-8C07F80B1345Q47929356-4771BEED-FE8B-4CC1-B8E5-8B2ACC5124BBQ48230865-C45A7279-A55D-418F-A933-0A08A1D1CDCCQ48332794-CC9B7710-5BA5-48D4-B3D3-CA23A71531F2Q55045242-6169A858-33B0-434A-8897-5A254E44DD06
P2860
SETBP1 mutation analysis in 944 patients with MDS and AML.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
SETBP1 mutation analysis in 944 patients with MDS and AML.
@en
SETBP1 mutation analysis in 944 patients with MDS and AML.
@nl
type
label
SETBP1 mutation analysis in 944 patients with MDS and AML.
@en
SETBP1 mutation analysis in 944 patients with MDS and AML.
@nl
prefLabel
SETBP1 mutation analysis in 944 patients with MDS and AML.
@en
SETBP1 mutation analysis in 944 patients with MDS and AML.
@nl
P2093
P2860
P50
P356
P1433
P1476
SETBP1 mutation analysis in 944 patients with MDS and AML.
@en
P2093
K J Suchanek
P2860
P2888
P304
P356
10.1038/LEU.2013.145
P577
2013-05-07T00:00:00Z